株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

核医学画像の実現技術

Technologies Enabling Nuclear Medicine Imaging

発行 Frost & Sullivan 商品コード 648614
出版日 ページ情報 英文 59 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.87円で換算しております。
Back to Top
核医学画像の実現技術 Technologies Enabling Nuclear Medicine Imaging
出版日: 2018年05月23日 ページ情報: 英文 59 Pages
概要

当レポートでは、核医学画像の実現技術の動向を調査し、核医学画像の定義と概要、分類、成長影響因子の分析、主要企業とイノベーションの概要、将来の研究の方向性、課題と提言、IP環境の分析などをまとめています。

第1章 エグゼクティブサマリー

第2章 技術概要・動向

  • 核医学:人体組織の生化学的機能の理解の鍵
  • 核医学画像・概要
  • 核医学画像の歴史的展望
  • 核医学画像の分類
  • 放射性医薬品
  • ガンマカメラ
  • SPECT
  • PET
  • 核医学画像データの定量化ソフトウェア

第3章 推進因子と障壁

  • 市場・技術の成長推進因子
  • 市場・技術の成長抑制因子

第4章 主要企業・イノベーションの概要

  • Philips Healthcare
  • General Electric
  • Siemens Healthineers

第5章 新しい市場機会

  • 患者のニーズに基づく技術カスタマイズ
  • 新薬の有効性・生化学的機能の評価
  • 迅速な診断・核医学の利用可能性の拡大

第6章 将来の核画像研究の方向性

  • 機能の改善:画像用途の拡大を支援
  • 複数の画像モダリティの組み合わせ:マルチモーダルスキャナーの創出
  • 小動物画像におけるイノベーションのニーズ
  • 新しい放射性トレーサーの開発ニーズ

第7章 核医学の進歩における課題と提言

  • 法規制上の課題
  • 医用放射性核種とトレーニングを受けた核医学者の不足

第8章 IP環境の分析

第9章 コンタクト情報・文献

  • 主要参入事業者のデータベース
目次
Product Code: D7EF

Redefining the Boundaries of Standard Medical Imaging through Nuclear Medicine

Tech Vision's latest research service from medical imaging technology cluster highlights the innovations and emerging technology trends in the domain of nuclear imaging. Nuclear imaging is evolving as a next frontier in the medical imaging industry. Nuclear imaging gained significant importance in medical industry space by understanding physiology of disease that helps in adressing the disease at early stages with faster and accurate diagnosis.

There is an increased adoption of nuclear imaging due to the developments of novel radiopharmaceuticals in new clinical areas like orthopaedicas and neurology when compared to traditionally used clinical areas like oncology and cardiology. However, the nuclear imaging inductry poised to face challenges like decreased federal support, heavy regulatory requirements, inadequate supply of radionuclides for research, etc. This report is key for strategies that can be employed the market participants to addess the industry challenges. The analysis would be key for the new entrants and established market players to create viable and implementable strategies to ensure continued innovations and stay competitive in nuclear imaging industry.

This research service sheds light on nuclear imaging technology landcape, key growth opportunities for research and development, associated regulatory and technology challenges and their corresponding recommendations, key company profiling, and intellectual property landscape.

Table of Contents

1.0. EXECUTIVE SUMMARY

  • 1.1. Scope of Research
  • 1.2. Research Methodology
  • 1.2. Research Methodology (continued)

2.0. TECHNOLOGY SNAPSHOT AND TRENDS

  • 2.1. Nuclear Medicine is Key to Understand Biochemical Functioning of Human Organs
  • 2.2. Nuclear Medical Imaging and its Brief overview
  • 2.3. Historical Perspective of Nuclear Medicine Imaging
  • 2.4. Nuclear Medicine Imaging Segmentation
  • 2.5. Nuclear Medicine Segmentation Based on Image Applications
  • 2.6. Radiopharmaceuticals Form the Integral Part of Nuclear Medicine
    • 2.6.1. Radiopharmaceuticals Segmentation Used in Infection Scintigraphy
    • 2.6.2. Clinically Used Radiopharmaceuticals and Radionuclides
  • 2.7. Gamma Camera in Nuclear Imaging
  • 2.8. Single photon emission computer tomography (SPECT) in nuclear imaging
  • 2.9. Positron Emission Tomography (PET) in Nuclear Imaging
  • 2.10. Software for Quantification of Nuclear Medicine Imaging Data

3.0. DRIVERS AND RESTRAINTS FOR NUCLEAR MEDICINE IMAGING

  • 3.1. Market and Technology Drivers Ranked in Order of Impact (Global), 2018-2024
    • 3.1.1. Adoption of Multimodality Imaging helped in Exploring Novel Therapeutic Areas
    • 3.1.2. Development in Informatics solutions eased the Imaging Analysis
    • 3.1.3. Nuclear Medicine Imaging facilitated more research into Neurodegenerative Diseases
    • 3.1.4. Development of Novel Radiopharmaceuticals helps in Targeting Unaddressed Therapeutic Areas
  • 3.2. Market and Technology Restraints Ranked in Order of Impact (Global), 2018-2024
    • 3.2.1. High Cost of Nuclear Imaging Modalities Making it Difficult to Reach Remote Areas Across the World
    • 3.2.2. Reduced Research Funding on Imaging Equipment and Novel Radiopharmaceuticals hampering the growth
    • 3.2.3. Time Consuming and Less Technology transfer from Laboratory to Commercial Market space

4.0. KEY COMPANIES AND THEIR INNOVATION SNAPSHOTS

  • 4.1. Company Innovation Profiling of Philips Healthcare
  • 4.2. Company Innovation Profiling of General Electric
  • 4.3. Company Innovation Profiling of Siemens Healthineers

5.0. EMERGING OPPORTUNITIES

  • 5.1. Customizing the Technology Based on Patients' Needs
  • 5.2. Assessing the Efficacy and Biochemical Functioning of New Drugs
  • 5.3. Faster Diagnosis and Increased Availability of Nuclear Medicine

6.0. FUTURE RESEARCH DIRECTION IN NUCLEAR IMAGING

  • 6.1. Improving Functionalities will Help Expand Imaging Applications
  • 6.2. Combining Imaging Modalities to Create Multi-modal Scanners
  • 6.3. Need for Innovations in Small Animal Imaging
  • 6.4. Need for Development of Novel Radiotracers

7.0. CHALLENGES TO ADVANCING NUCLEAR MEDICINE AND RECOMMENDATIONS

  • 7.1. Federal and Regulatory Challenges in Nuclear Medicine Imaging
  • 7.2. Shortage of Medical Radionuclides and Trained Nuclear Medicine Scientists

8.0. IP LANDSCAPE ANALYSIS

  • 8.1. Nuclear Medicine Imaging - Regional IP Analysis
  • 8.2. Nuclear Medicine Imaging - By Top Assignees
  • 8.3. The US is an Attractive Market and Tops the Chart in Terms of the Number of Technology Innovations Originated
  • 8.4. Patent filings related to Image Reconstruction using Nuclear Medicine
  • 8.5. Patent filing in Operational Methods and Attenuation Compensation in Nuclear Medicine Imaging
  • 8.6. Patents related to Performance Enhancement in Nuclear Medicine Imaging
  • 8.7. Key Patents related to PET Advancements and NM Imaging of Neurodegenerative Diseases

9.0. INDUSTRY CONTACTS AND REFERENCES

  • 9.1. Database of Key Industry Participants
  • 9.2. Database of Key Industry Participants and References
  • Legal Disclaimer
Back to Top